Related Experiment Videos
Factors affecting growth of normal and malignant cells in vitro
Biochemical Pharmacology
|June 15, 1976
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far.
Journal of human hypertension·2007
Improving prescribing using a rule based prescribing system.
Quality & safety in health care·2004
From minimal background diabetic retinopathy to profuse sight threatening vitreoretinal haemorrhage: management issues in a case of pregestational diabetes and pregnancy.
Diabetic medicine : a journal of the British Diabetic Association·2003
Recovery of renal function after autologous stem cell transplantation in myeloma patients with end-stage renal failure.
Bone marrow transplantation·2002
WTAP-mediated m6A modification upregulates the circCDK8 to promote ferroptosis in periodontal ligament stem cells.
Biochemical pharmacology·2026
Wogonoside: Pharmacology, molecular targets and therapeutic potential.
Biochemical pharmacology·2026
Disruption of gut bacteria-derived hydrogen sulfide signaling mediates antibacterial-induced acute anorexia.
Biochemical pharmacology·2026
Drug failure in diabetic kidney disease: translational barriers, target validation and trial de-risking strategies.
Biochemical pharmacology·2026
Exercise interventions remodel the aging microenvironment to improve prognosis in older patients with cancer.
Frontiers in immunology·2026
Dynamic junction remodeling and transient vascular disruption during cancer cell extravasation across the blood-brain barrier.
Frontiers in cell and developmental biology·2026
RUNX3+ basal-like malignant cells: architects of an immunosuppressive microenvironment in bladder cancer: a comprehensive bioinformatics analysis of single-cell and spatial transcriptomics.
International journal of surgery (London, England)·2026
CPT1A through succinylation regulates the CTCF/LINC01503‒91aa feedback loop to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
Clinical and translational medicine·2026